Suvretta Capital Management, Llc - Apr 9, 2025 SCHEDULE 13G Report for Monte Rosa Therapeutics, Inc. Common stock, par value $0.0001 per share (GLUE)

Filing Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Reporting Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Security
Monte Rosa Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol
GLUE
Shares outstanding
61.1M shares
Disclosed Ownership
3.36M shares
Ownership
5.5%
Form type
SCHEDULE 13G
Date filed
4/16/2025, 05:30 PM
Date of event
Apr 9, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SUVRETTA CAPITAL MANAGEMENT, LLC 5.5% 3.36M 0 3.36M By: /s/ Andrew Nathanson Andrew Nathanson/General Counsel and Chief Compliance Officer
Averill Master Fund, Ltd. 5.1% 3.15M 0 3.15M By: /s/ Andrew Nathanson Andrew Nathanson/Authorized Signatory
Aaron Cowen 5.5% 3.36M 0 3.36M By: /s/ Aaron Cowen Aaron Cowen